Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: sim1 who wrote (5883)	1/14/1999 9:47:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 6136

brought to you by the people that reported "flares" in HBV-positive patients after vaccination. So, first...... yeahrightsure. Next.... the immunization was before challenge. None of the monkeys was protected, and they report viral reduction in only one of three vaccinated monkeys. Sort of an embarrassing release, IMO. Someone at CYTL must have needed to sell some stock, but...... that wouldn't be a first for CYTL, eh?